Ticagrelor
Ticagrelor is a direct-acting, reversible P2Y12 receptor antagonist that inhibits platelet aggregation. It is widely used in cardiovascular disease research, with applications in both in vitro platelet function studies and in vivo models of thrombosis and acute coronary syndromes.
Product Specifications
CAS Number
274693-27-5
Product Name Alternative
Ticagrelor, CYP2C9, AZD6140, AZD-6140, AZD 6140, AR-C 126532XX, inhibit, P2YReceptor, P2Y12, P2Y Receptor, P2Y, Inhibitor
Field of Research
Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Purity
98.08% (May vary between batches)
Solubility
DMSO:250 mg/mL (478.4 mM) ;5% DMSO+40 % PEG300+5 % Tween 80+50 % Saline:5 mg/mL (9.57 mM)
Smiles
CCCSc1nc (N[C@@H]2C[C@H]2c2ccc (F) c (F) c2) c2nnn ([C@@H]3C[C@H] (OCCO) [C@@H] (O) [C@H]3O) c2n1
Molecular Formula
C23H28F2N6O4S
Molecular Weight
522.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
